Management and outcomes after neoadjuvant treatment for locally advanced breast cancer in older versus younger women

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Derks MGM, Bastiaannet E, Kiderlen M, et al. Variation in treatment and survival of older patients with non-metastatic breast cancer in five European countries: a population-based cohort study from the EURECCA breast cancer group. Br J Cancer. 2018;119(1):121–129.
   PubMed Web of Science ®Google Scholar
• Jensen JD, Cold S, Nielsen MH, et al. Trends in breast cancer in the elderly in Denmark, 1980–2012. Acta Oncol. 2016;55(1):59–64.
   PubMed Web of Science ®Google Scholar
• Land LH, Dalton SO, Jørgensen TL, et al. Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol. 2012;81(2):196–205.
   PubMed Web of Science ®Google Scholar
• Van De Water W, Bastiaannet E, Dekkers OM, et al. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg. 2012;99(6):813–820.
   PubMed Web of Science ®Google Scholar
• Hillner BE, Mandelblatt J. Caring for older women with breast cancer: can observational research fill the clinical trial gap? J Natl Cancer Inst. 2006;98(10):660–661.
   PubMedGoogle Scholar
• Angarita FA, Chesney T, Elser C, et al. Treatment patterns of elderly breast cancer patients at two Canadian cancer centres. Eur J Surg Oncol. 2015 May;41(5):625–634.
   PubMed Web of Science ®Google Scholar
• Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the international society of geriatric oncology (SIOG) and European society of breast cancer specialists (EUSOMA). Lancet Oncol. 2012;13(4):e148–e160.
   PubMed Web of Science ®Google Scholar
• Weggelaar I, Aben KK, Warlé MC, et al. Declined guideline adherence in older breast cancer patients: a population-based study in the Netherlands. Breast J. 2011;17(3):239–245.
   PubMed Web of Science ®Google Scholar
• Garg PK, Prakash G. Current definition of locally advanced breast cancer. Curr Oncol. 2015;22(5):409–410.
   PubMed Web of Science ®Google Scholar
• Cold F, Svolgaard O, Thygesen PH, et al. 461 Locally advanced breast cancer; twelve years results from a single institution. Eur J Cancer Suppl. 2010;8(3):193–194.
   Web of Science ®Google Scholar
• Hornova J, Bortlicek Z, Majkova P, et al. Locally advanced breast cancer in elderly patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017;161(2):217–222.
   PubMed Web of Science ®Google Scholar
• Christiansen P, Ejlertsen B, Jensen M-B, et al. Danish breast cancer cooperative group. Clin Epidemiol. 2016;8:445–449.
   PubMed Web of Science ®Google Scholar
• Vogsen M, Bille C, Jylling AMB, et al. Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008–2012. Acta Oncol. 2020;59(7):741–747.
   PubMed Web of Science ®Google Scholar
• Biganzoli L, Battisti NML, Wildiers H, et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European society of breast cancer specialists (EUSOMA) and the international society of geriatric oncology (SIOG). Lancet Oncol. 2021;22(7):e327–e340.
   PubMed Web of Science ®Google Scholar
• Saad ED, Squifflet P, Burzykowski T, et al. Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis. Lancet Oncol. 2019;20(3):361–370.
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247.
   PubMed Web of Science ®Google Scholar
• Koh J, Kim MJ. Introduction of a new staging system of breast cancer for radiologists: an emphasis on the prognostic stage. Korean J Radiol. 2019;20(1):69–82.
   PubMed Web of Science ®Google Scholar
• Jensen MB, Laenkholm AV, Offersen BV, et al. The clinical database and implementation of treatment guidelines by the Danish breast cancer cooperative group in 2007–2016. Acta Oncol. 2018;57(1):13–18.
   PubMed Web of Science ®Google Scholar
• Cao L, Sugumar K, Keller E, et al. Neoadjuvant endocrine therapy as an alternative to neoadjuvant chemotherapy among hormone receptor-positive breast cancer patients: pathologic and surgical outcomes. Ann Surg Oncol. 2021;28(10):5730–5741.
   PubMed Web of Science ®Google Scholar
• Delaloge S, Dureau S, D’Hondt V, et al. Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer. Eur J Cancer. 2022;166:300–308.
   PubMed Web of Science ®Google Scholar
• Prat A, Saura C, Pascual T, et al. Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial. Lancet Oncol. 2020;21(1):33–43.
   PubMed Web of Science ®Google Scholar
• Goetz MP, Okera M, Wildiers H, et al. Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials. Breast Cancer Res Treat. 2021;186(2):417–428.
   PubMed Web of Science ®Google Scholar
• Battisti NML, True V, Chaabouni N, et al. Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: the royal Marsden experience. Breast Cancer Res Treat. 2020;179(1):101–111.
   PubMed Web of Science ®Google Scholar
• Klein J, Tran W, Watkins E, et al. Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: a retrospective cohort analysis. BMC Cancer. 2019;19(1):306.
   PubMed Web of Science ®Google Scholar
• Verholt AB, Foss ACH, Christiansen P, et al. Non-surgically treated older women with operable early breast cancer in Denmark. Dan Med J. 2020;67(11):A04200226.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Bastiaannet E, Evers D, et al. Omission of surgery in elderly patients with early stage breast cancer. Eur J Cancer. 2013;49(3):545–552.
   PubMed Web of Science ®Google Scholar
• Fusco D, Allocca E, Villani ER, et al. An update in breast cancer management for elderly patients. Transl. Cancer Res. 2018;7(S3):S319–S328.
   Web of Science ®Google Scholar
• Tesarova P. Breast cancer in the elderly—should it be treated differently? Rep Pract Oncol Radiother. 2012;18(1):26–33.
   PubMedGoogle Scholar
• Rocco N, Rispoli C, Pagano G, et al. Breast cancer surgery in elderly patients: postoperative complications and survival. BMC Surg. 2013;13(S2):S25.
   PubMed Web of Science ®Google Scholar
• Katz SJ, Belkora J, Elwyn G. Shared decision making for treatment of cancer: challenges and opportunities. J Oncol Pract. 2014;10(3):206–208.
   PubMedGoogle Scholar